Printer friendly version
4th EMUC in Barcelona: Experts to examine impact of new therapies in uro-oncological diseases
16 November 2012 — 18 November 2012
European Association of Urology
From November 16 to 18, experts from medical oncology, urology and radiology will gather in Barcelona’s Catalonia Palace of Congresses to discuss on how best to complement and manage the various therapies being offered to patients with uro-oncological diseases. The event, which is being held annually starting this year, gathered last year around 900 cancer professionals not only from across Europe, but also from North America and other regions.
“We will continue to stimulate discussion and cooperation across disciplines and formulate optimal treatment strategies for onco-urological patients. At the same time, we will be zooming in on translational and basic science as well as technology, giving extra attention to some of the most forward-looking findings in the field,” said Prof. Manfred Wirth, EAU executive and member of the 4th EMUC Organising Steering Committee.
Emerging technologies such as combination drugs, imaging-based diagnosis and focal therapies for prostate and kidney cancers will be among the many issues that will be discussed in the two-and-half-day event.
Practice-oriented case discussions, debates, expert lectures and the main plenary sessions will scrutinise the treatment strategies of various disciplines. The best and latest studies from various top research centers in Europe will also be presented in abstracts sessions. This year a record number of 171 papers from 33 countries were submitted.
For the general press and specialised medical journals, there will be plenty of opportunities to get in touch with some of the world’s leading experts in uro-oncology.
“The value of this congress is not only to offer a dynamic platform for experts to discuss the controversial issues and attempt to share knowledge and find common ground, but also for the general public to learn more about the risks in uro-oncological diseases,” according to the organisers.
For more information, please visit the meeting's website: